Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aravive, Inc. | Chief Financial Officer | Stock Option (Right to buy) | 175K | Jan 24, 2022 | Direct | ||
Virpax Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (right to buy) | 112K | Jan 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRPX | Virpax Pharmaceuticals, Inc. | Jan 29, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Chief Financial Officer |
VRPX | Virpax Pharmaceuticals, Inc. | Jun 20, 2023 | 1 | $0 | 4/A | Aug 16, 2023 | Chief Financial Officer |
VRPX | Virpax Pharmaceuticals, Inc. | Jun 20, 2023 | 0 | $0 | 3 | Jun 21, 2023 | Chief Financial Officer |
ARAV | Aravive, Inc. | Jan 24, 2022 | 1 | $0 | 4 | Jan 25, 2022 | Chief Financial Officer |
ARAV | Aravive, Inc. | Jun 29, 2021 | 1 | $5.31K | 4 | Jun 29, 2021 | Chief Financial Officer |